OLLIE COMBS: Open Payments
NPI 1285018440 · MADISONVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,222 in 213 payments from 10 companies in 2025. Trend: 2023 $3,407 · 2024 $2,915 · 2025 $3,222
Food & beverage: $3,222
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 42 | $597 |
| E.R. Squibb & Sons, L.L.C. | 32 | $526 |
| Janssen Pharmaceuticals, Inc | 34 | $393 |
| Neurocrine BioSciences, Inc. | 20 | $385 |
| Otsuka America Pharmaceutical, Inc. | 16 | $330 |
| Lundbeck LLC | 19 | $302 |
| Vanda Pharmaceuticals Inc. | 17 | $291 |
| ABBVIE INC. | 25 | $232 |
| Teva Pharmaceuticals USA, Inc. | 5 | $86 |
| Alkermes, Inc. | 3 | $82 |
Products named: CAPLYTA, COBENFY, INVEGA SUSTENNA, INGREZZA, ABILIFY ASIMTUFII, VRAYLAR, FANAPT, ABILIFY MAINTENA.
Industry payments across KY — which companies pay providers there.
